Filing Details

Accession Number:
0001225208-14-008085
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-11 18:00:55
Reporting Period:
2014-03-07
Filing Date:
2014-03-11
Accepted Time:
2014-03-11 18:00:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812074 Owens Illinois Inc OI Glass Containers (3221) 222781933
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551683 Jr P Stephen Bramlage One Michael Owens Way
Perrysburg OH 43551
Senior Vice President And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock (Direct) Acquisiton 2014-03-07 7,436 $0.00 35,477 No 4 A Direct
Common Stock (Direct) Acquisiton 2014-03-07 3,600 $0.00 39,077 No 4 A Direct
Common Stock (Direct) Acquisiton 2014-03-07 757 $0.00 39,834 No 4 A Direct
Common Stock (Direct) Disposition 2014-03-07 5,002 $33.78 34,832 No 4 S Direct
Common Stock (Direct) Disposition 2014-03-10 4,000 $33.46 30,832 No 4 S Direct
Common Stock (Direct) Disposition 2014-03-10 10,394 $33.33 20,438 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 A Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock (Direct) Stock Option 3/07/2014 $33.62 Acquisiton 2014-03-07 18,755 $33.62 18,755 $33.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,755 2021-03-07 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Indirect) 750 Indirect By 401k
Footnotes
  1. The shares are subject to restrictions on sale that expire, either (i) as to 25% of the shares on each of the first four anniversaries of the date of grant of such shares, or (ii) in their entirety upon the grantee's death or disability prior to a termination of employment.
  2. The shares are subject to restrictions on sale that expire, either (i) as to 50% of the share on each of the first two anniversaries of the date of grant of such shares, or (ii) in their entirty upon the grantee's death or disability prior to a termination of employment.
  3. Restricted shares received by the reporting person on March 7, 2014 pursuant to action taken on that date by the Company's Compensation Committee determining the number of shares payable to the reporting person under certain restricted stock units granted for the 2011-2013 grant period. The restricted stock units did not constitute derivative securities on the date of grant thereof.
  4. Some of the shares were sold by the reporting person to cover the withholding tax on shares of restricted stock on which the restrictions lapsed and on shares payable under the restricted stock units granted for the 2011-2013 grant period.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.35, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.45 to $33.48, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.32 to $33.34, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  8. The option vests in four equal annual installments beginning on the first anniversary of the date of the grant.